Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Redemption Value Series 9 Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Total
Balance at Dec. 31, 2023			$ 26,330		$ (57,959)	$ (31,629)
Balance (in Shares) at Dec. 31, 2023		12,791
Common and preferred shares issued via merger	$ 11,302		14,303			25,605
Common and preferred shares issued via merger (in Shares)	11,302	8,303
Common shares issued for conversion of debt			9,614			9,614
Common shares issued for conversion of debt (in Shares)		11,551
Inducement loss on debt conversions			6,732			6,732
Common shares issued to Xeriant, Inc.
Common shares issued to Xeriant, Inc. (in Shares)		1,194
Common shares issued for cashless exercise of warrants and options
Common shares issued for cashless exercise of warrants and options (in Shares)		1,928
Capital contribution - forgiveness of related party payable			380			380
Stock-based compensation			5,792			5,792
Stock-based compensation (in Shares)		3,911
Cumulative translation adjustment				(166)		(166)
Series 9 preferred stock dividend accrued			(61)			(61)
Net loss					(2,602)	(2,602)
Balance at Mar. 31, 2024	$ 11,302		63,090	(166)	(60,561)	13,665
Balance (in Shares) at Mar. 31, 2024	11,302	39,678
Balance at Dec. 31, 2023			26,330		(57,959)	(31,629)
Balance (in Shares) at Dec. 31, 2023		12,791
Net loss						(21,747)
Balance at Sep. 30, 2024	$ 6,677		79,370	524	(79,706)	6,865
Balance (in Shares) at Sep. 30, 2024	6,677	152,036
Balance at Mar. 31, 2024	$ 11,302		63,090	(166)	(60,561)	13,665
Balance (in Shares) at Mar. 31, 2024	11,302	39,678
Common shares issued for net cash proceeds of ATM offering			8,675			8,675
Common shares issued for net cash proceeds of ATM offering (in Shares)		37,201
Common shares issued as settlement of accrued compensation			1,192			1,192
Common shares issued as settlement of accrued compensation (in Shares)		10,722
Common shares issued as prepayment for services			335			335
Common shares issued as prepayment for services (in Shares)		1,718
Stock-based compensation			(59)			(59)
Cumulative translation adjustment				(32)		(32)
Series 9 preferred stock dividend accrued			(250)			(250)
Change in fair value of convertible note receivable				59		59
Net loss					(14,710)	(14,710)
Balance at Jun. 30, 2024	$ 7,752		78,233	(139)	(75,271)	10,575
Balance (in Shares) at Jun. 30, 2024	7,752	107,367
Common shares issued in exchange of Series 9 Preferred Stock	$ (3,550)		3,727			177
Common shares issued in exchange of Series 9 Preferred Stock (in Shares)	(3,550)	11,997
Deemed dividend related to Series 9 Preferred Stock exchange			(177)			(177)
Common shares issued in exchange of warrants			1,981			1,981
Common shares issued in exchange of warrants (in Shares)		5,969
Deemed dividend related to December 2023 warrant exchange			(283)			(283)
Common shares issued for exercise of equity classified warrants			2			2
Common shares issued for exercise of equity classified warrants (in Shares)		82
Common shares issued for net cash proceeds of ATM offering			1,035			1,035
Common shares issued for net cash proceeds of ATM offering (in Shares)		12,762
Common shares issued as settlement of accrued compensation			1,101			1,101
Common shares issued as settlement of accrued compensation (in Shares)		11,100
Stock-based compensation			(1,889)			(1,889)
Stock-based compensation (in Shares)		4,020
Cumulative translation adjustment				663		663
Series 9 preferred stock dividend accrued			(185)			(185)
Net loss					(4,435)	(4,435)
Balance at Sep. 30, 2024	$ 6,677		79,370	524	(79,706)	6,865
Balance (in Shares) at Sep. 30, 2024	6,677	152,036
Common shares issued in exchange of Series 9 Preferred Stock	$ (1,075)		1,129			54
Common shares issued in exchange of Series 9 Preferred Stock (in Shares)	(1,075)	16,787
Deemed dividend related to Series 9 Preferred Stock exchange			(54)			(54)
Balance at Dec. 31, 2024	$ 1,331	$ 2	99,425	(622)	(93,562)	6,574
Balance (in Shares) at Dec. 31, 2024	1,331	1,685,021
Common shares issued for net cash proceeds of ATM offering			1,667			1,667
Common shares issued for net cash proceeds of ATM offering (in Shares)		169,299
Common shares issued for net cash proceeds of public offerings		$ 2	17,900			17,902
Common shares issued for net cash proceeds of public offerings (in Shares)		2,219,746
Common shares issued for conversion of debt			750			750
Common shares issued for conversion of debt (in Shares)		240,229
Common shares issued for exercise of liability classified warrants			408			408
Common shares issued for exercise of liability classified warrants (in Shares)		300,000
Redemption of Series 9 preferred stock	$ (1,331)		(96)			(1,427)
Redemption of Series 9 preferred stock (in Shares)	(1,331)
Stock-based compensation			455			455
Cumulative translation adjustment				467		467
Other		$ 1	4			5
Other (in Shares)		173,245
Net loss					(12,872)	(12,872)
Balance at Mar. 31, 2025		$ 5	120,513	(155)	(106,434)	13,929
Balance (in Shares) at Mar. 31, 2025		4,787,540
Balance at Dec. 31, 2024	$ 1,331	$ 2	99,425	(622)	(93,562)	6,574
Balance (in Shares) at Dec. 31, 2024	1,331	1,685,021
Net loss						(47,176)
Balance at Sep. 30, 2025		$ 31	150,263	898	(140,738)	10,454
Balance (in Shares) at Sep. 30, 2025		30,861,816
Balance at Mar. 31, 2025		$ 5	120,513	(155)	(106,434)	13,929
Balance (in Shares) at Mar. 31, 2025		4,787,540
Common shares issued for net cash proceeds of public offerings		$ 6	(457)			(451)
Common shares issued for net cash proceeds of public offerings (in Shares)		6,231,200
Common shares issued for exercise of liability classified warrants		$ 7	18,002			18,009
Common shares issued for exercise of liability classified warrants (in Shares)		6,771,600
Stock-based compensation			722			722
Stock-based compensation (in Shares)		125,000
Cumulative translation adjustment				1,039		1,039
Other			15			15
Net loss					(20,858)	(20,858)
Balance at Jun. 30, 2025		$ 18	138,795	884	(127,292)	12,405
Balance (in Shares) at Jun. 30, 2025		17,915,340
Common shares issued for net cash proceeds of public offerings		$ 12	3,121			3,133
Common shares issued for net cash proceeds of public offerings (in Shares)		11,946,000
Common shares issued for exercise of liability classified warrants		$ 1	1,997			1,998
Common shares issued for exercise of liability classified warrants (in Shares)		966,976
Stock-based compensation			6,350			6,350
Stock-based compensation (in Shares)		33,500
Cumulative translation adjustment				14		14
Net loss					(13,446)	(13,446)
Balance at Sep. 30, 2025		$ 31	$ 150,263	$ 898	$ (140,738)	$ 10,454
Balance (in Shares) at Sep. 30, 2025		30,861,816